Phase
Condition
Vomiting
Treatment
First patient Bupivacaine liposome and next patient Bupivacaine liposome
Next patients Bupivacaine liposome
First patient Bupivacaine liposome
Clinical Study ID
Ages 41-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 41-65 years ASA physical condition 1-2 BMI 18-30 kg/m2 undergoing arthroscopic shoulder surgery
Exclusion
Exclusion Criteria:
Inability to consent to the study pregnancy allergy to local anesthetics preexisting neuropathy cervical pathologies (i.e., herniated disc, myelopathy) chronic pain syndromes (defined as reflex sympathetic dystrophy or complex regional pain syndrome) severe respiratory conditions psychiatric or cognitive disorders that prohibit patients from adhering to the study protocol history of drug or alcohol abuse chronic opioid use (longer than 3 months or daily morphine equivalents more than 5mg/day for 1 month) contraindication for general anesthesia and/or interscalene nerve block and planned open shoulder arthrotomies Muscle related diseases
Study Design
Study Description
Connect with a study center
Affiliated Hospital of Jiaxing University
Jiaxing,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.